Exclusive Interview with GSK Released Ahead of Pharmaceutical Microbiology USA

San Diego, CA, March 22, 2017 --(PR.com)-- After the success of SMi’s Pharmaceutical Microbiology UK shows, the 7th in its series will launch stateside in California. The US programme will provide attendees with the latest updates in the pharmaceutical microbiology field from industry leading experts through a series of presentations, an extended training session and two pre-conference workshops. Topics that will be discussed include environmental monitoring, sterility assurance, endotoxin recovery, rapid microbial methods, data integrity and biofilms.

In the lead up to the event, SMi Group caught up with the chairman of day one and featured speaker Donald Singer, GSK Fellow, Steriles Microbiology, R&D from GSK for a quick Q & A session.

Donald will be providing the opening address on day one of the conference with his presentation entitled "Retracing the path to sterility assurance: A USP journey." He will touch upon: Updates on the latest revisions of USP microbiology chapters; work activities for revising chapters on sterility assurance and current thinking about sterile product evaluation topics (bacterial endotoxins testing, alternative pyrogen test, container closure integrity evaluation, sterility test).

Q&A snapshot:

SMi: What do you believe are the biggest challenges for you?

DS: Finding good placement of the new analytical technologies so that they provide value to our company, and developing sustainable knowledge in our company as it progresses through ongoing change and the industry compliance requirements increase.

For the full Q&A session, visit the download centre of the event website.
Running alongside the conference will be two pre-conference workshops held on the 7th June.

Workshop A: Technologies for Monitoring Contamination Control and Case Studies on Contamination Control. Hosted by Jim Polarine Jr, Senior Technical Service Manager, STERIS Corporation and Andrew Bartko, Research Leader, Battelle Memorial Institute.

Workshop B: Microbial Required Use for Terminal Sterilization. Hosted by Jerry Dalfors, Principal, JD Technologies

For those wanting to attend, there is currently an early bird offer available; book by 31st March to save $200 off the conference price. Register at www.pharma-microbiology-usa.com/prcom

Pharmaceutical Microbiology USA is sponsored by Charles River, Rapid Microbiosytems and Biomerieux

For sponsorship packages: Contact Alia Malick +44 (0) 207 827 6168 or e-mail amalick@smi-online.co.uk.

For delegate enquiries: Contact Fateja Begum on +44 (0) 20 7827 6184 or email
fbegum@smi-online.co.uk

For media enquiries, contact Zoe Gale on +44 (0) 20 7827 6138 or zgale@smi-online.co.uk

Pharmaceutical Microbiology USA
8 - 9 June 2017
San Diego, California, USA
www.pharma-microbiology-usa.com/prcom
Contact e-mail: zgale@smi-online.co.uk
Contact tel: +44 (0) 207 827 6184
#smimicrobiology

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk